AMRI Promotes Daniel Conlon to Senior Director of Business Development
News Sep 12, 2012
AMRI announce that Daniel Conlon has been promoted to Senior Director, Business Development, AMRI, reporting to Christopher Conway, Vice President, Business Development, North America. Daniel’s responsibilities will include assisting with the strategic direction for generating sales in the North American territory and with the execution of revenue goals for his team.
“Dan is a leader in the truest sense of the word,” Mr. Conway says. “He has the proven ability to energize a team while setting the highest attainable standards. Dan’s sales and management experience makes him ideal for this position.”
Conlon’s demonstrated knowledge and ability to sell AMRI’s development and manufacturing services earned him the top sales position in 2012. Before joining AMRI in 2010, Conlon held a sales and management position with Merck, formally Organon BioSciences. He worked for Merck/Organon for eight years starting as a Sales Representative/District Trainer. Following this role, he was promoted to District Sales Manager overseeing a team across multistate districts.
“The strengthening of our Business Development team will help us build upon an already solid foundation for growth and will further enhance AMRI’s strategic SMARTSOURCING™ approach,” said Thomas D’Ambra, Ph.D., AMRI’s Chairman, President and Chief Executive Officer. “We are very encouraged by the talented and motivated people on our team, and the prospects for continued growth in the future.”
15th International Conference on Surgical Pathology and Cancer Diagnosis
Apr 15 - Apr 16, 2019